Cargando…

Potential Role of the Sigma-1 Receptor Chaperone in the Beneficial Effects of Donepezil in Dementia with Lewy Bodies

Detalles Bibliográficos
Autor principal:	Hashimoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650298/ https://www.ncbi.nlm.nih.gov/pubmed/23678355 http://dx.doi.org/10.9758/cpn.2013.11.1.43

Ejemplares similares

Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
por: Mori, Etsuro, et al.
Publicado: (2012)

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial
por: Ikeda, Manabu, et al.
Publicado: (2015)

Dementia with Lewy Bodies and Alzheimer's Disease Sometimes Coexist
por: Kobayashi, Zen
Publicado: (2022)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Comment on “Neuropsychological Comparison of Patients With Alzheimer’s Disease and Dementia With Lewy Bodies”
por: Lee, Seon-Min, et al.
Publicado: (2023)

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
por: Mori, Etsuro, et al.
Publicado: (2015)

Association between clinical symptoms and post‐mortem neuropathology in dementia with Lewy bodies
por: Kaneko, Yoshitsugu, et al.
Publicado: (2020)

Reply to the letter titled, “Dementia with Lewy Bodies and Alzheimer's Disease Sometimes Coexist”
por: Tsujimoto, Masashi
Publicado: (2022)

T Lymphocytes and Their Potential Role in Dementia with Lewy Bodies
por: Amin, Jay, et al.
Publicado: (2023)

Absence of Alpha-Synuclein Pathology in the Stomach of a Patient With Prodromal Dementia With Lewy Bodies
por: Shin, Chaewon, et al.
Publicado: (2023)

Improvement of Visuo-spatial Function Assessed by Raven’s Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment
por: Yoshino, Yuta, et al.
Publicado: (2017)

Logopenic aphasia due to Lewy body disease dramatically improved with donepezil
por: Kakinuma, Kazuo, et al.
Publicado: (2020)

Re: Comments on “Neuropsychological Comparison of Patients With Alzheimer’s Disease and Dementia With Lewy Bodies”: Author Response
por: Kang, Sungwoo, et al.
Publicado: (2023)

Case report: Delusional infestation in dementia with Lewy bodies
por: Taomoto, Daiki, et al.
Publicado: (2022)

Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2009)

The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases
por: Penke, Botond, et al.
Publicado: (2018)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

A case of schizophrenia with Capgras delusion responded to donepezil
por: Halder, Ankit, et al.
Publicado: (2022)

Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19
por: Escobar-Cornejo, Guillermo Saúl, et al.
Publicado: (2022)

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies
por: Hatton, Christopher, et al.
Publicado: (2020)

Brainstem-Predominant Lewy-Related Pathology in a Patient with Parkinson’s Disease without Dementia
por: Choi, Ji-Hyun, et al.
Publicado: (2020)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2010)

Case Report: De Clerambault's Syndrome in Dementia With Lewy Bodies
por: Suehiro, Takashi, et al.
Publicado: (2021)

An Autopsy-Proven Case of Lewy Body Disease Presenting with Severe Dysphagia
por: Jo, Sungyang, et al.
Publicado: (2021)

A proteomic signature for dementia with Lewy bodies
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Anosognosia in dementia with Lewy bodies: a systematic review
por: CALIL, Victor, et al.
Publicado: (2021)

The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions
por: Orme, Tatiana, et al.
Publicado: (2018)

Delusional parasitosis in dementia with Lewy bodies: a case report
por: Ochiai, Sho, et al.
Publicado: (2019)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gl4bvfpkvrh59a0vi4fdfuhb2q